Dementia draws over prescribing drugs as it is improperly treating an approximately 179,000 residents with Dementia each week indicating usage of chemical constraints according to a new Human Rights Watch report.

A report titled “They want Docile” professes thousands of abiding nursing-home patients with Dementia are prescribed unbefitting antipsychotic drugs not made for them. In numerous cases, the report mentions antipsychotics are giving due to their tranquilizing effect for ease of handling the dementia patients.

Antipsychotic drugs bearing a significant warning from the US Food and Drug Administration vociferated as the “black box,” because the drugs rise up dementia patient’s risk of death. The drugs were developed to treat psychiatric conditions such as schizophrenia.

Hannah Flamm, an NYU law school fellow at Human Rights Watch said that people suffering from Dementia are often tranquilized to make their day to day endeavors smooth and easy as the government doesn’t do much for such endangered patients. Many times staff provides explanation utilizing antipsychotic drugs over people with dementia as they translate pressing voice of pain and anguish as ingenious operation that needs to be subdued.

This report is published at the time where lawmakers and researchers are deterrent of a wave of aging baby boomers. Presently, more than 5 million Americans have Alzheimer’s, and one in three seniors expires with Alzheimer’s or another dementia. The number of people with Alzheimer’s could triple by 2050.  Researchers with Human Rights Watch spoke to 323 people and paid a visit to 109 nursing homes in California, Florida, Illinois, Kansas, New York and Texas between October 2016 and March 2017.They utilized Federal data to appraise the percentage of patients nationally who unbecomingly sustain such drugs.

Researchers discovered specimens where patients were not made aware of the risks of antipsychotic drugs, or sensed their near and dears would be discarded from a facility if they were taken off the drugs.